H-VYGGSKTSL-OH

Rif. 3D-PP44930

Informazioni sul prodotto

• Nome: H-VYGGSKTSL-OH
• Sinonimi: NH2-Val-Tyr-Gly-Gly-Ser-Lys-Thr-Ser-Leu-OH

Descrizione

Peptide H-VYGGSKTSL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VYGGSKTSL-OH include the following: Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw* 0303-and-Cw* 0304-restricted epitope on Y Ito, A Demachi-Okamura, R Ohta - Journal of general , 2007 - microbiologyresearch.orghttps://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.82519-0 Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells S Mukherjee, P Trivedi , DM Dorfman , G Klein - The Journal of , 1998 - rupress.orghttps://rupress.org/jem/article-abstract/187/3/445/7417 Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity J Tellam, G Connolly, N Webb, J Duraiswamy - Blood, 2003 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/102/13/4535/17459 Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition J Tellam , M Sherritt, S Thomson, R Tellam - Journal of Biological , 2001 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)34721-0/abstract Analisi delle proprietaca immunologiche e carcinogeniche di Epstein-Barr Nuclear Antigen 1 D Marescotti - 2009 - sfera.unife.ithttps://sfera.unife.it/handle/11392/2389129

• Marchio: Biosynth